| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/26/2009 | US20090053301 Silicone vesicles containing actives |
| 02/26/2009 | US20090053286 Products and methods for maintaining or increasing ceramide levels in skin |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053230 Anti-ox40l antibodies and methods using same |
| 02/26/2009 | US20090053163 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 02/26/2009 | US20090053146 Metronidazole-based dermatological foams and emulsions for the preparation thereof |
| 02/26/2009 | US20090053144 Reduction in bacterial colonization by administering bacteriophage compositions |
| 02/26/2009 | DE202008000654U1 Zusammensetzung zur Behandlung von Haut-, Haar- und Nagelerkrankungen und -problemen Composition for the treatment of skin, hair and nail diseases and problems |
| 02/26/2009 | DE102007040000A1 Zwitterionische Verbindungen und deren Verwendung Zwitterionic compounds and their use |
| 02/26/2009 | DE102007039229A1 Wasser- und wirkstoffhaltiges Gel Water and gel containing active ingredients |
| 02/26/2009 | CA2734577A1 Inflammation-regulating compositions and methods |
| 02/26/2009 | CA2697020A1 Method of producing plant extract formulations |
| 02/26/2009 | CA2696793A1 Novel preparation for external use |
| 02/25/2009 | EP2028276A1 Method for production of acetic acid bacterium-type ceramide |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2026879A2 Use of peptides as active slimming ingredients |
| 02/25/2009 | EP2026802A2 Jnk inhibitors for treatment of skin diseases |
| 02/25/2009 | EP2026779A1 Use of a composition consisting of a combination of hydroquinone, fluocinolone acetonide and tretinoin, intended for treatment signs of photoaging of the skin |
| 02/25/2009 | EP2026778A2 Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects |
| 02/25/2009 | EP1556020B1 Use of cgrp antagonist compounds for treatment of psoriasis |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101374860A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 02/25/2009 | CN101374571A Na/K-ATPase ligand |
| 02/25/2009 | CN101374542A Bovine osteopontin formulations for the improvement of the wound healing process |
| 02/25/2009 | CN101374541A Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101374524A Combination of mTOR inhibitor and antipolate compound |
| 02/25/2009 | CN101372459A Zwitterionic compounds and use thereof |
| 02/25/2009 | CN101371925A Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof |
| 02/25/2009 | CN101371911A Chinese medicinal composition for treating flat wart |
| 02/25/2009 | CN101371904A Chinese herbal medicine for treating alopecia and preparation method thereof |
| 02/25/2009 | CN101371889A A set of medicament prescription for treating skin tinea and preparation method thereof |
| 02/25/2009 | CN101371880A Chinese medicinal composition for treating empyrosis wound surface |
| 02/25/2009 | CN101371878A External-use Chinese medicinal composition for treating painful swelling disease |
| 02/25/2009 | CN101371848A Medicament for treating burn and scald |
| 02/25/2009 | CN101371846A Liquid medicine for curing burn and preparation method thereof |
| 02/25/2009 | CN101371833A Use of 1-aryl-2(1H)-pyridinone compounds in preparing medicament for curing skin pruritus |
| 02/25/2009 | CN101371818A A process for the preparation of ferutinine from Ferula genus plants |
| 02/25/2009 | CN100463697C Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant external ointments |
| 02/25/2009 | CN100463688C Ointment with aloe and other five medicinal herbs and its preparation method |
| 02/25/2009 | CN100463668C Reversibly hot gelified water soluble medicine composition |
| 02/25/2009 | CN100463666C Composition for external use on skin |
| 02/25/2009 | CN100463611C Processing method of natural bamboo juice soy sauce |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |
| 02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
| 02/24/2009 | US7494669 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | US7494503 Method and apparatus for acne prevention |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2362601C Deep penetrating antimicrobial compositions |
| 02/23/2009 | CA2639780A1 Zwitterionic compounds and use thereof |
| 02/20/2009 | CA2597971A1 Method and composition for repairing epithelial and other cells and tissue |
| 02/19/2009 | WO2009022894A1 Pharmaceutical composition combining an antiandrogenic agent, a synthetic steroidal estrogenic agent and vitamin agents, which can be used to control and treat late-onset female acne |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009022430A1 Skin whitening agent |
| 02/19/2009 | WO2009021696A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | WO2008155520A3 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 02/19/2009 | WO2008152333A3 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 02/19/2009 | WO2008148967A3 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
| 02/19/2009 | WO2008060130A4 Detergent compositions in the form of microemulsions and use thereof in the treatment of alopecia |
| 02/19/2009 | WO2008046083A3 Use of oxindole compounds as therapeutic agents |
| 02/19/2009 | WO2003097072A9 Chloasma amelioration composition and dullness amelioration composition |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048339 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
| 02/19/2009 | US20090048338 Biologically active oils |
| 02/19/2009 | US20090048295 Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereof |
| 02/19/2009 | US20090048289 Administration of tropisetron for treating inflammatory skin diseases/disorders |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048211 External preparation composition |
| 02/19/2009 | US20090048210 Agent for therapy or treatment of wound |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048182 Cosmetic Use of at Least One Natural Ac-N-Ser-Asp-Lys-Pro-Tetrapeptide or One of Its Analogues as Agent for Slowing Down Loss of Hair and/or Stimulating Hair Growth |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047371 Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field |
| 02/19/2009 | US20090047359 Ointment for combating and treating skin diseases, and process for preparing said ointment |
| 02/19/2009 | US20090047341 Capsules of core/shell type and preparation process |
| 02/19/2009 | US20090047331 Sustained release film formulation for healing wound comprising epidermal growth factor |
| 02/19/2009 | US20090047314 Microencapsulation systems and applications of same |
| 02/19/2009 | US20090047264 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/19/2009 | US20090047258 Compositions and methods for reversing age-related changes in extracellular matrix proteins |
| 02/19/2009 | US20090047254 Bacteriophage and their uses |
| 02/19/2009 | US20090047242 Conditioned blood composition and method for its production |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | DE102007038098A1 Tyrosinaseinhibitoren Tyrosinase |
| 02/19/2009 | DE102007038097A1 Tyrosinaseinhibitoren Tyrosinase |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/18/2009 | EP2025752A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 02/18/2009 | EP2025681A2 Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions |
| 02/18/2009 | EP2025667A1 9,10-secopregnane derivative and pharmaceutical |